Patients who should wait before starting BPC-157: those with active malignancy or a personal history of hormone-sensitive cancer, pregnant patients, and anyone who has not yet completed a basic anti-inflammatory protocol for an acute injury
It can also be lab-synthesized
And for folks to do that, is that a simple Google search or just kind of asking
Dehydroascorbate is reduced to ASC by DHAR, using the electron from GSH, which is therefore oxidized to glutathione disulfide (GSSG)
It provides enough peptide for 5-10 weeks at starting doses of 1-2mg, which covers the entire initial escalation phase
After 3 weeks of treatment, mice were euthanized, and excised tumors were weighed